Safety and effectiveness of tocilizumab in systemic sclerosis: a multicentre French-Italian study. [PDF]
Buonsante G +29 more
europepmc +1 more source
Clinical and psychosocial determinants of oral handicap in systemic sclerosis: a cross-sectional study. [PDF]
Erdoğan Soysal M +3 more
europepmc +1 more source
Palliative care in systemic sclerosis: incorporating advance care planning into longitudinal care. [PDF]
Savoie MB, Logeman JL, Castelino FV.
europepmc +1 more source
Scleroderma renal crisis: avoiding the diagnostic pitfalls of an elusive condition. [PDF]
Ng IKS, Tang MS, See FH, Cho J.
europepmc +1 more source
Gastrointestinal Disorders in Scleroderma. [PDF]
Quigley EMM +3 more
europepmc +1 more source
Lung Auscultation for Detecting Interstitial Lung Disease in Patients with Newly Diagnosed Systemic Sclerosis: Retrospective Cohort Study. [PDF]
Wireko FW +6 more
europepmc +1 more source
Severe scleroderma colopathy at initial diagnosis of systemic sclerosis in a young man: a case report. [PDF]
Alshamisti MI +6 more
europepmc +1 more source
Nodular Scleroderma: Characterization of a Distinct Clinical Phenotype.
Nodular scleroderma is a rare variant of systemic sclerosis (SSc) characterized by fleshy, indurated nodules commonly distributed over the upper and lower extremities and in the trunk.
Somashekar, Anupam, MD +5 more
core
Clinical characteristics, autoantibody profiles, and therapeutic outcomes of juvenile systemic sclerosis: an 11-year single-center experience from China. [PDF]
Wang Y +5 more
europepmc +1 more source
Probabilistic Clustering Using Multivariate Growth Mixture Model in Clinical Settings-A Scleroderma Example. [PDF]
Kim JS +5 more
europepmc +1 more source

